Search by Drug Name or NDC

    NDC 63629-2373-01 Chlordiazepoxide Hydrochloride and Clidinium Bromide 5; 2.5 mg/1; mg/1 Details

    Chlordiazepoxide Hydrochloride and Clidinium Bromide 5; 2.5 mg/1; mg/1

    Chlordiazepoxide Hydrochloride and Clidinium Bromide is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE.

    Product Information

    NDC 63629-2373
    Product ID 63629-2373_63c2bb31-d823-4b66-9967-cdc0ecfb556c
    Associated GPIs 49109902450110
    GCN Sequence Number 004902
    GCN Sequence Number Description chlordiazepoxide/clidinium Br CAPSULE 5 MG-2.5MG ORAL
    HIC3 J2B
    HIC3 Description ANTICHOLINERGICS,QUATERNARY AMMONIUM
    GCN 74801
    HICL Sequence Number 002037
    HICL Sequence Number Description CHLORDIAZEPOXIDE/CLIDINIUM BROMIDE
    Brand/Generic Generic
    Proprietary Name Chlordiazepoxide Hydrochloride and Clidinium Bromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Chlordiazepoxide Hydrochloride and Clidinium Bromide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 5; 2.5
    Active Ingredient Units mg/1; mg/1
    Substance Name CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
    Labeler Name Bryant Ranch Prepack
    Pharmaceutical Class Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA211421
    Listing Certified Through 2024-12-31

    Package

    NDC 63629-2373-01 (63629237301)

    NDC Package Code 63629-2373-1
    Billing NDC 63629237301
    Package 100 CAPSULE in 1 BOTTLE (63629-2373-1)
    Marketing Start Date 2022-06-24
    NDC Exclude Flag N
    Pricing Information N/A